Ritu Baral
Stock Analyst at TD Cowen
(4.96)
# 116
Out of 5,065 analysts
1047
Total ratings
51.7%
Success rate
42.4%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVA Inventiva | Reiterated: Buy | $10 | $2.98 | +235.57% | 9 | Sep 28, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | n/a | $8.36 | - | 6 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $71 | $40.24 | +76.44% | 6 | Sep 14, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $78 | $28.92 | +169.71% | 27 | Aug 31, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | n/a | $2.17 | - | 25 | Aug 13, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.7001 | +1,042.69% | 36 | Aug 12, 2026 | |
| NGNE Neurogene | Reiterated: Buy | n/a | $24.17 | - | 24 | Aug 11, 2026 | |
| VTVT vTv Therapeutics | Reiterated: Buy | $67 | $26.94 | +148.70% | 4 | Aug 7, 2026 | |
| GHRS GH Research | Reiterated: Buy | n/a | $18.28 | - | 15 | Aug 6, 2026 | |
| INSM Insmed | Reiterated: Buy | $243 | $95.29 | +155.01% | 73 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.82 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $510 | $260.17 | +96.03% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 | $17.73 | -4.12% | 104 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 | $19.80 | +86.87% | 66 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $11.11 | +161.03% | 23 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $267 | $122.96 | +117.14% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $403 | $320.25 | +25.84% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $482 | $233.29 | +106.61% | 101 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $644 | $447.09 | +44.04% | 45 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.01 | - | 9 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $12.94 | +255.49% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €8.90 | €2.71 | +228.98% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.82 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $8.86 | +137.02% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.12 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.35 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.1012 | n/a | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3776 | n/a | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.37 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8987 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20.75 → $20.41 | $2.24 | n/a | 7 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $40.40 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.15 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $44.38 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.38 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $61.53 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.07 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.20 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.75 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6651 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.65 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.80 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.42 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.63 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $0.97 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $233.48 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $11.53 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.000135 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.56 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.08 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $16.35 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.49 | n/a | 1 | Feb 21, 2012 |
Inventiva
Sep 28, 2026
Reiterated: Buy
Price Target: $10
Current: $2.98
Upside: +235.57%
Benitec Biopharma
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.36
Upside: -
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $71
Current: $40.24
Upside: +76.44%
Vera Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $78
Current: $28.92
Upside: +169.71%
Ovid Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.17
Upside: -
Milestone Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7001
Upside: +1,042.69%
Neurogene
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.17
Upside: -
vTv Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $67
Current: $26.94
Upside: +148.70%
GH Research
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.28
Upside: -
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $243
Current: $95.29
Upside: +155.01%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.82
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $510
Current: $260.17
Upside: +96.03%
Aug 6, 2026
Rated: Hold
Price Target: $17
Current: $17.73
Upside: -4.12%
Aug 5, 2026
Rated: Buy
Price Target: $37
Current: $19.80
Upside: +86.87%
Aug 5, 2026
Reiterated: Buy
Price Target: $29
Current: $11.11
Upside: +161.03%
Aug 4, 2026
Reiterated: Buy
Price Target: $267
Current: $122.96
Upside: +117.14%
Aug 3, 2026
Reiterated: Buy
Price Target: $403
Current: $320.25
Upside: +25.84%
Jul 31, 2026
Rated: Buy
Price Target: $482
Current: $233.29
Upside: +106.61%
Jul 30, 2026
Reiterated: Buy
Price Target: $644
Current: $447.09
Upside: +44.04%
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.01
Upside: -
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $12.94
Upside: +255.49%
Jun 8, 2026
Reiterated: Buy
Price Target: €8.90
Current: €2.71
Upside: +228.98%
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.82
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $21
Current: $8.86
Upside: +137.02%
Nov 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.12
Upside: -
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.35
Upside: -
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.1012
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.3776
Upside: n/a
Apr 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.37
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.8987
Upside: n/a
Apr 18, 2023
Downgraded: Hold
Price Target: $20.75 → $20.41
Current: $2.24
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $40.40
Upside: n/a
Mar 16, 2020
Reiterated: Buy
Price Target: n/a
Current: $21.15
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: n/a
Current: $44.38
Upside: n/a
Feb 24, 2020
Reiterated: Buy
Price Target: n/a
Current: $12.38
Upside: n/a
May 8, 2019
Reiterated: Hold
Price Target: n/a
Current: $61.53
Upside: n/a
Jan 6, 2019
Reiterated: Buy
Price Target: n/a
Current: $15.07
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $22.20
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $2.75
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.6651
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $62.65
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $20.80
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $2.42
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $4.63
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $0.97
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $233.48
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $11.53
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.000135
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.56
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.08
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $16.35
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $7.49
Upside: n/a